Invention Grant
- Patent Title: Immunogenic composition
-
Application No.: US15819312Application Date: 2017-11-21
-
Publication No.: US10286055B2Publication Date: 2019-05-14
- Inventor: Guido Grandi , Immaculada Margarit Y Ros , Domenico Maione
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GlaxosmithKline Biologicals SA
- Current Assignee: GlaxosmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Agent Virginia G. Campen
- Main IPC: A61K9/00
- IPC: A61K9/00 ; C12N7/00 ; A61K39/09 ; A61K39/00 ; A61K39/05 ; A61K39/08 ; A61K39/02 ; A61K39/13 ; A61K39/12 ; A61K47/64

Abstract:
Methods for raising an immune response in a mammal, by administration of an immunogenic composition comprising capsular saccharides from Streptococcus agalactiae (GBS) serotypes conjugated to carrier proteins.
Public/Granted literature
- US20180104324A1 IMMUNOGENIC COMPOSITION Public/Granted day:2018-04-19
Information query